Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Current Debt (2025)

Updated

Vitaspring Biomedical's Current Debt was $15.00 in fiscal Q1 2026 (quarter ended Apr 30, 2025).

Analysis

Vitaspring Biomedical (VSBC) Current Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 15.00
API Access

Vitaspring Biomedical Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=VSBC&period=max&api_key=YOUR_API_KEY